Markova, M. and Hristov, G. 2023. Reporting of R&D Costs Under IAS 38 – The Case of Biopharmaceutical Companies. Research Papers. 4 (Jan. 2023), 57–65. DOI:https://doi.org/https://doi.org/10.37075/RP.2022.4.04.